About Protein IFIT1 homolog B
Protein IFIT1 homolog B (IFIT1B) is a protein
from Homo sapiens identified by UniProt accession
Q5T764, 474 residues long.
MolForge cross-references it against 0 known binders and
56 disease associations.
Target properties
| Protein name | Protein IFIT1 homolog B |
| UniProt accession | Q5T764 |
| Gene | IFIT1B |
| Organism | Homo sapiens |
| Length | 474 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (56)
Diseases linked to this target (Open Targets).
- pathological myopia · score 0.11
- Myopia · score 0.11
- varicella, severe recurrent · score 0.06
- immunodeficiency 31B · score 0.06
- Chronic mucocutaneous candidosis · score 0.06
- Immunodeficiency by defective expression of HLA class 2 · score 0.05
- T-B+ severe combined immunodeficiency due to JAK3 deficiency · score 0.04
- hyper-IgM syndrome type 2 · score 0.04
- isolated agammaglobulinemia · score 0.04
- immunodeficiency 66 · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5T764-F1 | alphafold | PREDICTED | 93.32 | — |
Amino-acid sequence (474 residues)
MSEESDGKLI EDSLIQLRCH FTWKLLIEAP EIPDLENRIW EEIQFLDTKY NVGIHNLLAY VKHLKGQNEE ALVSLKKAED LIQKEHANQA DIRSLVTWGN FAWVYYHMGR LAEAQTYLDK VENTCKKFAN PSRYRMECPE VDCEEGWALA KCGGKNYERA KTCFEKALEG NPENPEFNTG YAITVYRLDK FNTASGRNKA FSLHVLKRAV RLNPDDVYIR VLLALKLQDE GQEAEGEKYI EEALTSISSQ AYVFQYAAKF YRRKGSVDKA LELLKMALET TPTSAFLHHQ MGLCYRAQMI QIKEATNWQP RGQDRETVDR LVQLAICKFE KTIMLKRTFE MAYVDLAETY AEIGHHRKAE EHFQKGLRMK IFEDQLKQEI HYHYGRFQEH HGKSQDKAIT HYLKGLKIEK MSHSREKLLN ALEKLAKRCI HQNVRVVESV SLLGLIHKLK GEVSDALLCY ERALRLAADL NPIF
Explore Protein IFIT1 homolog B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets